Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

PROCTER & GAMBLE HEALTH vs DIVIS LABORATORIES - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    PROCTER & GAMBLE HEALTH DIVIS LABORATORIES PROCTER & GAMBLE HEALTH/
DIVIS LABORATORIES
 
P/E (TTM) x 34.5 66.2 52.1% View Chart
P/BV x 10.5 7.2 146.8% View Chart
Dividend Yield % 2.0 0.9 231.8%  

Financials

 PROCTER & GAMBLE HEALTH   DIVIS LABORATORIES
EQUITY SHARE DATA
    PROCTER & GAMBLE HEALTH
Jun-23
DIVIS LABORATORIES
Mar-23
PROCTER & GAMBLE HEALTH/
DIVIS LABORATORIES
5-Yr Chart
Click to enlarge
High Rs5,3664,641 115.6%   
Low Rs3,8832,730 142.2%   
Sales per share (Unadj.) Rs740.7292.6 253.2%  
Earnings per share (Unadj.) Rs138.268.7 201.3%  
Cash flow per share (Unadj.) Rs155.281.6 190.1%  
Dividends per share (Unadj.) Rs95.0030.00 316.7%  
Avg Dividend yield %2.10.8 252.4%  
Book value per share (Unadj.) Rs447.6480.9 93.1%  
Shares outstanding (eoy) m16.60265.47 6.3%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x6.212.6 49.6%   
Avg P/E ratio x33.553.7 62.3%  
P/CF ratio (eoy) x29.845.2 66.0%  
Price / Book Value ratio x10.37.7 134.8%  
Dividend payout %68.743.7 157.3%   
Avg Mkt Cap Rs m76,761978,378 7.8%   
No. of employees `000NANA-   
Total wages/salary Rs m2,0629,750 21.1%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m12,29677,675 15.8%  
Other income Rs m1843,447 5.3%   
Total revenues Rs m12,48081,122 15.4%   
Gross profit Rs m3,24723,691 13.7%  
Depreciation Rs m2813,432 8.2%   
Interest Rs m820 39.3%   
Profit before tax Rs m3,14223,686 13.3%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m8475,453 15.5%   
Profit after tax Rs m2,29518,234 12.6%  
Gross profit margin %26.430.5 86.6%  
Effective tax rate %27.023.0 117.1%   
Net profit margin %18.723.5 79.5%  
BALANCE SHEET DATA
Current assets Rs m11,71397,437 12.0%   
Current liabilities Rs m6,79115,331 44.3%   
Net working cap to sales %40.0105.7 37.9%  
Current ratio x1.76.4 27.1%  
Inventory Days Days2638 3,136.1%  
Debtors Days Days343842 40.8%  
Net fixed assets Rs m10,61751,128 20.8%   
Share capital Rs m166531 31.3%   
"Free" reserves Rs m7,265127,140 5.7%   
Net worth Rs m7,431127,671 5.8%   
Long term debt Rs m00-   
Total assets Rs m22,330148,565 15.0%  
Interest coverage x409.11,209.5 33.8%   
Debt to equity ratio x00-  
Sales to assets ratio x0.60.5 105.3%   
Return on assets %10.312.3 83.9%  
Return on equity %30.914.3 216.2%  
Return on capital %42.418.6 228.3%  
Exports to sales %085.7 0.0%   
Imports to sales %13.119.8 65.9%   
Exports (fob) Rs mNA66,537 0.0%   
Imports (cif) Rs m1,60515,378 10.4%   
Fx inflow Rs m1,46566,537 2.2%   
Fx outflow Rs m1,60515,715 10.2%   
Net fx Rs m-14050,822 -0.3%   
CASH FLOW
From Operations Rs m2,36024,597 9.6%  
From Investments Rs m-215-27,076 0.8%  
From Financial Activity Rs m-985-7,972 12.4%  
Net Cashflow Rs m1,160-10,451 -11.1%  

Share Holding

Indian Promoters % 0.0 51.9 -  
Foreign collaborators % 51.8 0.0 -  
Indian inst/Mut Fund % 20.3 36.7 55.1%  
FIIs % 7.6 14.9 51.2%  
ADR/GDR % 0.0 0.0 -  
Free float % 48.2 48.1 100.2%  
Shareholders   56,730 354,482 16.0%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare PROCTER & GAMBLE HEALTH With:   SUN PHARMA    CIPLA    DR. REDDYS LAB    ZYDUS LIFESCIENCES    MANKIND PHARMA    


More on Procter & Gamble Health vs Divis Laboratories

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

Procter & Gamble Health vs Divis Laboratories Share Price Performance

Period Procter & Gamble Health Divis Laboratories S&P BSE HEALTHCARE
1-Day -0.40% 2.56% 1.29%
1-Month -7.32% -1.74% -0.64%
1-Year -2.87% 23.01% 62.00%
3-Year CAGR -9.07% -1.24% 18.20%
5-Year CAGR 5.79% 15.86% 19.81%

* Compound Annual Growth Rate

Here are more details on the Procter & Gamble Health share price and the Divis Laboratories share price.

Moving on to shareholding structures...

The promoters of Procter & Gamble Health hold a 51.8% stake in the company. In case of Divis Laboratories the stake stands at 51.9%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of Procter & Gamble Health and the shareholding pattern of Divis Laboratories.

Finally, a word on dividends...

In the most recent financial year, Procter & Gamble Health paid a dividend of Rs 95.0 per share. This amounted to a Dividend Payout ratio of 68.7%.

Divis Laboratories paid Rs 30.0, and its dividend payout ratio stood at 43.7%.

You may visit here to review the dividend history of Procter & Gamble Health, and the dividend history of Divis Laboratories.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Rallies 550 Points| Nifty Tops 22,250 | Power Stocks Shine Sensex Today Rallies 550 Points| Nifty Tops 22,250 | Power Stocks Shine(10:30 am)

Asian markets traded lower, while the US stock indices ended higher overnight with the S&P 500 hitting a record closing high ahead of key economic data.